Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumothorax-II

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Outcomes after pulmonary bilobectomy for NSCLC: The role of surgical type, indication, and pulmonary function.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026

Same author

A single-center experience in parenchyma-sparing surgical treatment of malignant pleural mesothelioma.

Updates in surgery·2026

Same author

Mitomycin C in the Endoscopic Treatment of Airway Stenosis: A Systematic Review and a Meta-Analysis.

The Annals of otology, rhinology, and laryngology·2026

Same author

Predictors of Recurrence After Surgery in Patients with Stage I Non-Small Cell Lung Cancer.

Cancers·2026

Same author

Malignant Pleural Mesothelioma (MPM) Evaluation with [<sup>11</sup>C]-Methionine PET/CT Before and After Talc Pleurodesis.

Molecular imaging and biology·2026

Same author

Inflammatory Indices Related to the Postoperative Prognosis of Thymic Epithelial Neoplasms: A Propensity Score Matching Evaluation.

Annals of surgical oncology·2026

Search research articles

Related Experiment Video

Updated: Dec 7, 2025

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy

Published on: April 19, 2024

Pulmonary Lobectomy After COVID-19.

Alberto Testori¹, Gianluca Perroni¹, Emanuele Voulaz¹

¹Humanitas Clinical and Research Center - IRCCS, Thoracic Surgery Department, Rozzano, Milan, Italy.

The Annals of Thoracic Surgery

|September 28, 2020

Summary

Previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection does not appear to increase surgical risks after lung cancer treatment. A patient with lung cancer underwent successful surgery for adenocarcinoma with no complications.

More Related Videos

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

Related Experiment Videos

Last Updated: Dec 7, 2025

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy

Published on: April 19, 2024

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

Area of Science:

Thoracic surgery
Oncology
Infectious disease

Background:

Concomitant coronavirus disease 19 (COVID-19) increases surgical complication risks, particularly in thoracic procedures involving lung manipulation.
The impact of prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on postoperative outcomes after radiologic resolution remains unclear.

Observation:

A young patient with lung cancer was evaluated for thoracic surgery.
The patient had a history of prior SARS-CoV-2 infection.

Findings:

The patient successfully underwent a right upper lobectomy for primary adenocarcinoma via video-assisted thoracoscopic surgery.
No complications were observed during the early postoperative phase.

Implications:

This case suggests that prior SARS-CoV-2 infection may not preclude successful thoracic surgery once radiologic resolution is achieved.
Further research is warranted to confirm the safety of subsequent surgical procedures in patients with a history of SARS-CoV-2 infection.